Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $684.98 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $169.64 | 6 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $139.57 | 2 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $85.99 | 1 | $0 (2017) |
| Allergan, Inc. | $41.09 | 2 | $0 (2020) |
| Amarin Pharma Inc. | $36.96 | 2 | $0 (2020) |
| InSightec,Inc | $27.68 | 2 | $0 (2023) |
| UCB, Inc. | $27.13 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $26.80 | 2 | $0 (2019) |
| ZS Pharma. Inc. | $22.02 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $18.96 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $169.80 | 4 | Janssen Pharmaceuticals, Inc ($127.29) |
| 2022 | $27.43 | 1 | PFIZER INC. ($27.43) |
| 2021 | $92.32 | 4 | PFIZER INC. ($80.04) |
| 2020 | $103.18 | 5 | PFIZER INC. ($28.56) |
| 2019 | $109.21 | 7 | AstraZeneca Pharmaceuticals LP ($26.80) |
| 2017 | $183.04 | 5 | BOSTON SCIENTIFIC CORPORATION ($85.99) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2023 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $14.97 | General |
| Category: Neurology | ||||||
| 06/29/2023 | Mylan Specialty L.P. | GLATIRAMER ACETATE (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Immunomodulators | ||||||
| 04/15/2023 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $12.71 | General |
| Category: Neurology | ||||||
| 01/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $127.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/03/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/02/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/29/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/15/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/09/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiovascular | ||||||
| 03/03/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Neuroscience | ||||||
| 02/27/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Diabetes | ||||||
| 02/19/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: UROLOGY | ||||||
| 11/11/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2019 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: VACCINES | ||||||
| 10/29/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/03/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $33.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/29/2017 | ZS Pharma. Inc. | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2017 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN DEVICE (Device) | Food and Beverage | In-kind items and services | $85.99 | General |
| Category: STRUCTURAL HEART | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 362 | 574 | $219,670 | $48,524 |
| 2022 | 9 | 530 | 759 | $224,554 | $59,572 |
| 2021 | 10 | 553 | 785 | $195,062 | $60,191 |
| 2020 | 10 | 317 | 412 | $127,961 | $37,040 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 113 | 280 | $75,600 | $17,799 | 23.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 83 | 87 | $65,250 | $11,687 | 17.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 70 | 107 | $41,195 | $10,350 | 25.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 81 | 85 | $33,575 | $7,700 | 22.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 15 | $4,050 | $987.90 | 24.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 144 | 288 | $64,019 | $16,608 | 25.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 98 | 165 | $48,549 | $13,583 | 28.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 68 | $40,668 | $10,901 | 26.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 105 | 106 | $33,624 | $8,990 | 26.7% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 31 | 31 | $17,031 | $4,420 | 26.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 36 | 37 | $9,990 | $2,035 | 20.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 24 | 24 | $4,680 | $1,363 | 29.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 27 | $2,842 | $924.99 | 32.5% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 12 | 13 | $3,151 | $747.53 | 23.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 137 | 305 | $57,015 | $18,066 | 31.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 96 | 139 | $36,309 | $11,712 | 32.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 93 | 95 | $25,582 | $8,333 | 32.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 44 | 45 | $23,189 | $7,122 | 30.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 47 | 47 | $21,773 | $6,819 | 31.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 57 | 58 | $15,660 | $3,279 | 20.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 28 | 28 | $5,160 | $1,652 | 32.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 24 | 40 | $4,176 | $1,355 | 32.4% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 12 | 12 | $3,116 | $932.96 | 29.9% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 15 | 16 | $3,082 | $920.74 | 29.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 38 | 39 | $22,290 | $6,790 | 30.5% |
About Dr. Nelson Smith, MD
Dr. Nelson Smith, MD is a Hospitalist healthcare provider based in Winter Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760421895.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nelson Smith, MD has received a total of $684.98 in payments from pharmaceutical and medical device companies, with $169.80 received in 2023. These payments were reported across 26 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($684.98).
As a Medicare-enrolled provider, Smith has provided services to 1,762 Medicare beneficiaries, totaling 2,530 services with total Medicare billing of $205,327. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Hospitalist, Internal Medicine
- Location Winter Park, FL
- Active Since 06/05/2006
- Last Updated 12/18/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1760421895
Products in Payments
- ELIQUIS (Drug) $169.64
- XARELTO (Drug) $139.57
- WATCHMAN DEVICE (Device) $85.99
- Vascepa (Drug) $36.96
- Exablate (Device) $27.68
- Vimpat (Drug) $27.13
- FARXIGA (Drug) $26.80
- BRILINTA (Drug) $22.02
- VRAYLAR (Drug) $20.89
- LINZESS (Drug) $20.20
- MYRBETRIQ (Drug) $18.96
- Ozempic (Drug) $17.90
- FLUBLOK QUADRIVALENT (Drug) $14.88
- GLATIRAMER ACETATE (Drug) $14.83
- ANORO (Drug) $14.29
- EMGALITY (Drug) $14.05
- ENTRESTO (Drug) $13.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Winter Park
Ronald Gonzales, Md, MD
Hospitalist — Payments: $62,934
Avdesh Buragadda, Md, MD
Hospitalist — Payments: $1,821
Denyce Nichols, M.d, M.D
Hospitalist — Payments: $1,434
Jomeo Padavil, Md, MD
Hospitalist — Payments: $1,210
Victoire Kelley, Md, MD
Hospitalist — Payments: $613.64
Diana Koshy, M.d, M.D
Hospitalist — Payments: $387.65